Evidence map›Paper›PMID 36504564›Full record

ArticleAvicenna journal of medical biotechnology

Bioactive Materials Derived from Menstrual Blood Stem Cells Enhance the Quality of

Mohammad Sobhan Amini, Mohammad Mehdi Naderi, Abolfazl Shirazi, Mehdi Aminafshar, Sara Borjian Boroujeni, Mostafa Pournourali, Ali Malekpour

Open access · greenAbstract read
In one paragraph

Article in Avicenna journal of medical biotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Extracellular vesicles: key mediators inFrontiers in veterinary science · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mohammad Sobhan AminiDepartment of Animal Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Mohammad Mehdi NaderiReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Abolfazl ShiraziReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Mehdi AminafsharDepartment of Animal Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Sara Borjian BoroujeniReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Mostafa PournouraliReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Ali MalekpourReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Academic Center for Education, Culture and Research · IRBiotechnology Research Center · IRIslamic Azad University, Science and Research Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backgrounds: The aim of this study was to determine whether the addition of bioactive materials derived from Menstrual Blood Stem Cells (MenSCs) to the oocyte maturation medium may improve the quality of bovine embryos Methods: MenSCs were collected from 6 healthy women (between 26 and 36 years old) and after 3 days of culture, their bioactive materials were frozen. The bovine Cumulus-Oocyte-Complexes (COCs) were aspirated from ovarian slaughterhouse and the oocytes with more than three layers of cumulus cells were cultured Results: The blastocyst rate on day 8 in treatment group was higher than control (40.2±1.9 Conclusion: In conclusion, the addition of MenSCs' bioactive materials during

Indexed as

BovineEmbryoIn vitro productionIVMMenstrual blood stem cells

Identifiers

PMID36504564
PMCPMC9706245
OpenAlexW4294716586

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.